State Street® SPDR® S&P® Biotech ETF XBI

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XBI

Will XBI outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street® SPDR® S&P® Biotech ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XBI

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 18.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

2.37 259M
Healthcare

Natera Inc

1.82 199M
Healthcare

Halozyme Therapeutics Inc

1.77 193M
Healthcare

Twist Bioscience Corp

1.77 193M
Healthcare

Biogen Inc

1.75 191M
Healthcare

Amgen Inc

1.73 189M
Healthcare

Exelixis Inc

1.73 189M
Healthcare

United Therapeutics Corp

1.72 187M
Healthcare

AbbVie Inc

1.71 186M
Healthcare

Gilead Sciences Inc

1.70 186M
Healthcare

Sponsor Center